These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1752960)

  • 21. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha.
    Romero R; Maymon E; Pacora P; Gomez R; Mazor M; Yoon BH; Berry SM
    Am J Obstet Gynecol; 2000 Nov; 183(5):1070-7. PubMed ID: 11084543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor-alpha modulates the expression of its p60 receptor and several cytokines in rat tracheal epithelial cells.
    Bader T; Nettesheim P
    J Immunol; 1996 Oct; 157(7):3089-96. PubMed ID: 8816419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P
    J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
    van Riemsdijk-van Overbeeke IC; Baan CC; Hesse CJ; Loonen EH; Niesters HG; Zietse R; Weimar W
    Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A tumor necrosis factor binding protein is present in human biological fluids.
    Peetre C; Thysell H; Grubb A; Olsson I
    Eur J Haematol; 1988 Nov; 41(5):414-9. PubMed ID: 2850215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor alpha.
    Lang CH; Frost RA
    Metabolism; 2007 Jan; 56(1):49-57. PubMed ID: 17161226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms.
    Lantz M; Björnberg F; Olsson I; Richter J
    J Immunol; 1994 Feb; 152(3):1362-9. PubMed ID: 7905502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis.
    Dinarello CA
    Kidney Int Suppl; 1992 Oct; 38():S68-77. PubMed ID: 1328757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in ligand binding specificities of a novel class of poxvirus-encoded tumor necrosis factor-binding protein.
    Rahman MM; Barrett JW; Brouckaert P; McFadden G
    J Biol Chem; 2006 Aug; 281(32):22517-26. PubMed ID: 16782702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
    Kitazawa R; Kimble RB; Vannice JL; Kung VT; Pacifici R
    J Clin Invest; 1994 Dec; 94(6):2397-406. PubMed ID: 7989596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell density-dependent regulation of cell surface expression of two types of human tumor necrosis factor receptors and its effect on cellular response.
    Pocsik E; Mihalik R; Ali-Osman F; Aggarwal BB
    J Cell Biochem; 1994 Apr; 54(4):453-64. PubMed ID: 8014194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein.
    Alon R; Cahalon L; Hershkoviz R; Elbaz D; Reizis B; Wallach D; Akiyama SK; Yamada KM; Lider O
    J Immunol; 1994 Feb; 152(3):1304-13. PubMed ID: 7905501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation.
    Kondo S; Sauder DN
    Eur J Immunol; 1997 Jul; 27(7):1713-8. PubMed ID: 9247582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble and cell surface receptors for tumor necrosis factor.
    Wallach D; Engelmann H; Nophar Y; Aderka D; Kemper O; Hornik V; Holtmann H; Brakebusch C
    Agents Actions Suppl; 1991; 35():51-7. PubMed ID: 1664189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour necrosis factor is trafficked to a mitochondrial tumour necrosis factor binding protein.
    Ledgerwood EC; Prins JB; Bright NA; Johnson DR; Wolfreys K; Pober JS; O'Rahilly S; Bradley JR
    Biochem Soc Trans; 1998 Nov; 26(4):S316. PubMed ID: 10047830
    [No Abstract]   [Full Text] [Related]  

  • 37. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
    Mohler KM; Torrance DS; Smith CA; Goodwin RG; Stremler KE; Fung VP; Madani H; Widmer MB
    J Immunol; 1993 Aug; 151(3):1548-61. PubMed ID: 8393046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta.
    Terlizzese M; Simoni P; Antonetti F
    J Interferon Cytokine Res; 1996 Dec; 16(12):1047-53. PubMed ID: 8974008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
    Frishman JI; Edwards CK; Sonnenberg MG; Kohno T; Cohen AM; Dinarello CA
    J Infect Dis; 2000 Dec; 182(6):1722-30. PubMed ID: 11069245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of TNF binding proteins.
    Engelmann H; Aderka D; Wallach D
    Methods Mol Med; 2004; 98():23-32. PubMed ID: 15064430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.